Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Raymond Lab, |
RCV000850194 | SCV000897731 | likely pathogenic | Intellectual disability | 2019-02-13 | criteria provided, single submitter | research | |
Invitae | RCV001040610 | SCV001204194 | pathogenic | Charcot-Marie-Tooth disease, type I | 2019-12-17 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the MPZ gene (p.Ile162Metfs*90). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 87 amino acids of the MPZ protein and extend the protein by an additional 2 amino acids. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 25614874). ClinVar contains an entry for this variant (Variation ID: 625199). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant disrupts the region of the MPZ protein between p.Arg98 and p.Ser233. This region has been determined to be associated with autosomal dominant MPZ-related conditions (PMID: 7688964, 15729519, 20461396), which suggests that variants that occur in this region are likely to be clinically significant. For these reasons, this variant has been classified as Pathogenic. |
Inherited Neuropathy Consortium | RCV000790075 | SCV000929465 | pathogenic | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |